Mirae Asset Global Investments’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.5K | Buy |
2,945
+406
| +16% | +$4.62K | ﹤0.01% | 1313 |
|
|
2025
Q1 | $30.8K | Buy |
2,539
+178
| +8% | +$2.16K | ﹤0.01% | 1325 |
|
|
2024
Q4 | $45.1K | Buy |
2,361
+31
| +1% | +$592 | ﹤0.01% | 1278 |
|
|
2024
Q3 | $53.7K | Buy |
2,330
+559
| +32% | +$12.9K | ﹤0.01% | 1292 |
|
|
2024
Q2 | $36.7K | Sell |
1,771
-29,133
| -94% | -$604K | ﹤0.01% | 1298 |
|
|
2024
Q1 | $316K | Buy |
30,904
+6,628
| +27% | +$67.8K | ﹤0.01% | 2088 |
|
|
2023
Q4 | $251K | Sell |
24,276
-3,099
| -11% | -$32K | ﹤0.01% | 2269 |
|
|
2023
Q3 | $215K | Sell |
27,375
-676
| -2% | -$5.31K | ﹤0.01% | 2266 |
|
|
2023
Q2 | $280K | Sell |
28,051
-1,486
| -5% | -$14.8K | ﹤0.01% | 2207 |
|
|
2023
Q1 | $262K | Buy |
29,537
+5,279
| +22% | +$46.9K | ﹤0.01% | 2230 |
|
|
2022
Q4 | $266K | Buy |
24,258
+19
| +0.1% | +$209 | ﹤0.01% | 2202 |
|
|
2022
Q3 | $316K | Buy |
24,239
+14,141
| +140% | +$184K | ﹤0.01% | 2139 |
|
|
2022
Q2 | $128K | Buy |
+10,098
| New | +$128K | ﹤0.01% | 2264 |
|